Project Grant S10OD036457
- This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1,980,309 to Yale University for the purchase of an Orbitrap Astral mass spectrometer system. The Orbitrap Astral offers state-of-the-art capabilities in proteomics research, including the ability to identify over 9,000 proteins in a 15-minute liquid chromatography gradient and 12,000 proteins in a 60-minute gradient. This cutting-edge instrument will...
- This $1,658,828 Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will enable the acquisition of a Thermo Scientific Orbitrap Astral Mass Spectrometer for the Mass Spectrometry Facility & Proteomics Center at the Medical University of South Carolina (MUSC) in Charleston. This state-of-the-art mass spectrometry instrument will support NIH-funded research across numerous disease areas, including cancer, immunotherapy,...
- The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) awarded a $1,960,930 Project Grant (CFDA 93.351) to Rutgers, The State University of New Jersey to acquire a Thermo Orbitrap Astral Mass Spectrometer for the Center for Advanced Proteomics Research on the Newark campus. This high-sensitivity mass spectrometer will enhance proteomics research capabilities supporting over 150 NIH-funded projects at Rutgers. The instrument's advanced data-independent...
- This $2,000,000 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) supports the upgrade and maintenance of a 14T/600 MHz high-field nuclear magnetic resonance (NMR) spectrometer and microimager at Massachusetts General Hospital (MGH). This cutting-edge biomedical research instrument has made significant contributions to diverse fields, including contrast agent development, tissue pathology, and the study of conditions like...
- The federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1 to Wayne State University to acquire a Thermo Fisher Scientific Orbitrap Astral mass spectrometer with High-Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS Pro Duo) device, an Aria instrument control and data management system, and a nano-LC system. The goal is to enhance the proteomics research capabilities at the Wayne State University...
- This $949,116 Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system at the University of South Florida (USF). This cutting-edge analytical instrumentation will establish a unique omics capability at USF to support detailed, high-resolution structural analysis of low-level small molecules in complex...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $738,090 to the University of California, Irvine (UCI) to acquire a refurbished Orbitrap Tribrid mass spectrometer. The instrument will be used to enhance quantitative protein-based mass spectrometry experiments in support of several NIH-funded research programs at UCI, including investigations of viral molecular structures,...
- The National Institutes of Health Office of the Director awarded Stanford University $3.8 million under the Research Infrastructure Programs grant program (CFDA 93.351) to acquire a new Orbitrap Tribrid mass spectrometry platform. For over 20 years, Stanford University Mass Spectrometry has served as the campus-wide shared proteomics resource, housing and maintaining mass spectrometry instruments to support numerous NIH-funded biomedical research projects spanning human development, degenerative...
- The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) awarded a $255,500 Project Grant (CFDA 93.351) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a new digital multi-isotope autoradiography system. This advanced imaging equipment will be housed at the Institute for Innovation in Imaging at MGH and will provide highly sensitive, real-time analysis of isotope distribution in tissue samples. The award,...
- This federal Project Grant award of $1,205,941 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) will enable the Salk Institute for Biological Studies to acquire a high-resolution Thermo Fisher Scientific Orbitrap IQ-X Tribrid mass spectrometer with a UHPLC system. This state-of-the-art instrumentation will enhance the institute's mass spectrometry core capabilities, allowing for improved detection and structural...
The National Institutes of Health (NIH) awarded a $1,352,820 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to the Massachusetts General Hospital (MGH) to acquire a novel high-throughput and high-sensitivity mass spectrometer called the Orbitrap Astral. This state-of-the-art instrument will be used to conduct proteomic research focused on cancer and Alzheimer's disease at MGH. The Orbitrap Astral's unprecedented speed and sensitivity are expected to enable new discoveries, including the identification of disease biomarkers and vulnerabilities that could lead to improved detection, monitoring, and treatment of these complex medical conditions. The grant award period runs from August 1, 2024, to July 31, 2025. The mass spectrometer will be made available to NIH-funded researchers nationwide to support a broad range of collaborative proteomics projects beyond the work at MGH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.4m | 7/26/24 |